Andrew Pike

Regioselective Oxidative Arylation of Indoles Bearing <i>N-</i>Alkyl Protecting Groups: Dual C−H Functionalization via a Concerted Metalation−Deprotonation Mechanism

Shathaverdhan Potavathri, Kyle C. Pereira, Serge I. Gorelsky et al. · Journal of the American Chemical Society · 2010 · 292 citations

Chemical Engineering, Cross-coupling Reaction, Engineering +14

Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride (LY 156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity

Charles D. Jones, Mary G. Jevnikar, Andrew Pike et al. · Journal of Medicinal Chemistry · 1984 · 282 citations

TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2 H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates

John Atack, Keith A. Wafford, Spencer J. Tye et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 187 citations

Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines

Per Sauerberg, Preben H. Olesen, Susanne Nielsen et al. · Journal of Medicinal Chemistry · 1992 · 162 citations · Full text

Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT_1D Receptor Ligands with Improved Pharmacokinetic Profiles

Monique B. van Niel, Ian Collins, Margaret S. Beer et al. · Journal of Medicinal Chemistry · 1999 · 157 citations · Full text

Combinatorial Chemistry, Molecular Pharmacology, Medicinal Chemistry +15